The Effect of Oral Fluid Administration 1 Hour Before Surgery on Preoperative Anxiety and Gastric Volume in Pediatrics
NCT ID: NCT05592964
Last Updated: 2022-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2022-03-04
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Standard fasting group.
Fasting
Standard fasting
Group S
The patient group who were given oral 5 ml/kg (maximum 250 ml) of water 1 hour ago.
Water
In Group S, water was given 1 hour before the operation.
Group K
The patient group who were given an oral 5 ml/kg (maximum 250 ml) carbohydrate rich clear liquid 1 hour ago.
Carbohydrate fluid
In Group K, carbohydrate fluid was given 1 hour before the operation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fasting
Standard fasting
Water
In Group S, water was given 1 hour before the operation.
Carbohydrate fluid
In Group K, carbohydrate fluid was given 1 hour before the operation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA Score of 1-2
Exclusion Criteria
* functional or anatomical disease related to the gastrointestinal tract, those with severe liver, kidney, cardiac or neurological disease
* patients using proton pump inhibitor or histamine 2 receptor blocker.
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zehra Hatipoglu, MD
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cukurova University, Faculty of Medicine, Department of Anesthesiology and Reanimation
Adana, Saricam, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10/2022
Identifier Type: -
Identifier Source: org_study_id